Feb 13, 2017
Prima BioMed Receives ~A$860,000 Tax Credit Payment from French Government
Jan 23, 2017
Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference
Jan 20, 2017
Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer
Jan 18, 2017
Prima BioMed to Maintain NASDAQ Listing
Jan 12, 2017
Prima BioMed Commences Recruitment for Second Cohort of Melanoma Trial
